Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $16.0 million.

  • Beta Bionics' Other Operating Expenses rose 6635.56% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.9 million, marking a year-over-year increase of 11259.42%. This contributed to the annual value of $37.1 million for FY2024, which is 20930.78% up from last year.
  • Beta Bionics' Other Operating Expenses amounted to $16.0 million in Q3 2025, which was up 6635.56% from $15.6 million recorded in Q2 2025.
  • Beta Bionics' Other Operating Expenses' 5-year high stood at $16.0 million during Q3 2025, with a 5-year trough of $7.7 million in Q1 2024.